A1AS_CAVPO
ID A1AS_CAVPO Reviewed; 405 AA.
AC P22325;
DT 01-AUG-1991, integrated into UniProtKB/Swiss-Prot.
DT 01-AUG-1991, sequence version 1.
DT 03-AUG-2022, entry version 115.
DE RecName: Full=Alpha-1-antiproteinase S;
DE Short=APS;
DE AltName: Full=Alpha-1-antitrypsin;
DE AltName: Full=Alpha-1-proteinase inhibitor;
DE Flags: Precursor;
OS Cavia porcellus (Guinea pig).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Glires; Rodentia; Hystricomorpha; Caviidae;
OC Cavia.
OX NCBI_TaxID=10141;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 25-44 AND 75-93.
RX PubMed=1985973; DOI=10.1016/s0021-9258(17)35262-6;
RA Suzuki Y., Yoshida K., Honda E., Sinohara H.;
RT "Molecular cloning and sequence analysis of cDNAs coding for guinea pig
RT alpha 1-antiproteinases S and F and contrapsin.";
RL J. Biol. Chem. 266:928-932(1991).
CC -!- FUNCTION: Inhibits elastase, chymotrypsin, cathepsin G, plasmin, and
CC trypsin.
CC -!- SUBCELLULAR LOCATION: Secreted.
CC -!- INDUCTION: APS rose several hundred-fold during the acute phase
CC reaction.
CC -!- DOMAIN: The reactive center loop (RCL) extends out from the body of the
CC protein and directs binding to the target protease. The protease
CC cleaves the serpin at the reactive site within the RCL, establishing a
CC covalent linkage between the carboxyl group of the serpin reactive site
CC and the serine hydroxyl of the protease. The resulting inactive serpin-
CC protease complex is highly stable (By similarity). {ECO:0000250}.
CC -!- SIMILARITY: Belongs to the serpin family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; M57270; AAA62805.1; -; mRNA.
DR PIR; A39088; A39088.
DR RefSeq; NP_001166205.1; NM_001172734.1.
DR AlphaFoldDB; P22325; -.
DR SMR; P22325; -.
DR STRING; 10141.ENSCPOP00000011412; -.
DR MEROPS; I04.001; -.
DR Ensembl; ENSCPOT00000012808; ENSCPOP00000011412; ENSCPOG00000012686.
DR GeneID; 100379265; -.
DR KEGG; cpoc:100379265; -.
DR CTD; 10603; -.
DR eggNOG; KOG2392; Eukaryota.
DR GeneTree; ENSGT00940000154493; -.
DR HOGENOM; CLU_023330_2_1_1; -.
DR InParanoid; P22325; -.
DR OMA; MEAIPMS; -.
DR OrthoDB; 1124079at2759; -.
DR TreeFam; TF343201; -.
DR Proteomes; UP000005447; Unassembled WGS sequence.
DR Bgee; ENSCPOG00000012686; Expressed in liver and 4 other tissues.
DR GO; GO:0005615; C:extracellular space; IEA:InterPro.
DR GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW.
DR GO; GO:0006953; P:acute-phase response; IEA:UniProtKB-KW.
DR Gene3D; 2.30.39.10; -; 1.
DR Gene3D; 3.30.497.10; -; 1.
DR InterPro; IPR023795; Serpin_CS.
DR InterPro; IPR023796; Serpin_dom.
DR InterPro; IPR000215; Serpin_fam.
DR InterPro; IPR036186; Serpin_sf.
DR InterPro; IPR042178; Serpin_sf_1.
DR InterPro; IPR042185; Serpin_sf_2.
DR PANTHER; PTHR11461; PTHR11461; 1.
DR Pfam; PF00079; Serpin; 1.
DR SMART; SM00093; SERPIN; 1.
DR SUPFAM; SSF56574; SSF56574; 1.
DR PROSITE; PS00284; SERPIN; 1.
PE 1: Evidence at protein level;
KW Acute phase; Direct protein sequencing; Glycoprotein; Protease inhibitor;
KW Reference proteome; Secreted; Serine protease inhibitor; Signal.
FT SIGNAL 1..24
FT /evidence="ECO:0000269|PubMed:1985973"
FT CHAIN 25..405
FT /note="Alpha-1-antiproteinase S"
FT /id="PRO_0000032382"
FT REGION 360..379
FT /note="RCL"
FT SITE 369..370
FT /note="Reactive bond"
FT CARBOHYD 57
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT CARBOHYD 94
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT CARBOHYD 157
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT CARBOHYD 258
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
SQ SEQUENCE 405 AA; 45125 MW; 5D41D48E1E078AA8 CRC64;
MPSAIPRGLL LLAGLCCLVF GIMAEDAQVA QGPSQQIPRS LAHFAHSMYR VLTQQSNTSN
IFFSPVSIAT ALAMVSVGAK GDTHTQILRG LEFNLTEIAE ADIHNGFQNL LHTLNRPHSE
HQLTTGNGLF LDQKLKLKEK FSEDVKTLYH AEAFPTNFSN PKEAEKQINA YVEKGTQGKI
VDLVKDLSAD TVLALVNYIF FRGKWEKPFD VKHTTQEDFH VDTSTTVKVP MMKREGKYKA
FHCSTIQSWV LLLDYEGNVT ALFLLPEEGK MQHLEETLTP ELIFKFARKT ERMFANVHLP
KLSISGTYDL KEVLGHLGIT NVFSDAADLS GVTEDIPLKI SKGLHKALLT IDEKGTEAAG
ATMMEFMPMS LPEDLSFNKP FLFLIIDHST DTPLFVGKVM DPTKK